more_reports

Soleno Therapeutics Inc.

SLNO:NASDAQ

Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company's lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, is currently being evaluated in a Phase III clinical development program.

streetwise book logo Streetwise Company Fact Sheet

2025/10/13 15:53:16

(SLNO:NASDAQ)

Streetwise Reports Articles

03/25/2025 - View Article
01/05/2024 - View Article

streetwise book logoStreetwise - Soleno Therapeutics Inc. Ownership Overview*

Soleno Therapeutics Inc. (SLNO:NASDAQ)

*Share Structure as of 3/25/2025